These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3347143)

  • 1. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
    Mishra PK; Dailey JW; Reigel CE; Jobe PC
    Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ro 4-1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats.
    Jobe PC; Brown RD; Dailey JW
    Life Sci; 1981 May; 28(18):2031-8. PubMed ID: 6909499
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
    Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
    Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
    Epilepsia; 1991; 32(2):168-73. PubMed ID: 2004621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ro 4-1284 on electrically-induced spinal cord seizures and on spinal cord norepinephrine and 5-hydroxytryptamine levels.
    Jobe PC; Ray TB; Geiger PF; Bourn WM
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):601-12. PubMed ID: 243955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
    Seo DO; Shin CY; Ryu JR; Cheong JH; Choi CR; Dailey JW; Reith ME; Jobe PC; Ko KH
    Eur J Pharmacol; 2000 May; 396(2-3):53-8. PubMed ID: 10822056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat.
    Dailey JW; Reigel CE; Mishra PK; Jobe PC
    Epilepsy Res; 1989; 3(1):3-17. PubMed ID: 2563686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
    Merrill MA; Clough RW; Jobe PC; Browning RA
    Epilepsia; 2005 Sep; 46(9):1380-8. PubMed ID: 16146432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
    Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific distinctions in audiogenic convulsions exhibited by severe seizure genetically epilepsy-prone rats (GEPR-9s).
    Mishra PK; Dailey JW; Reigel CE; Tomsic ML; Jobe PC
    Epilepsy Res; 1988; 2(5):309-16. PubMed ID: 3197700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audiogenic convulsions in moderate seizure genetically epilepsy-prone rats (GEPR-3s).
    Mishra PK; Dailey JW; Reigel CE; Jobe PC
    Epilepsy Res; 1989; 3(3):191-8. PubMed ID: 2731518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats.
    Jobe PC; Dailey JW; Reigel CE
    Life Sci; 1986 Sep; 39(9):775-82. PubMed ID: 3747729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
    Fuller RW; Hemrick-Luecke SK
    Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.
    Clough RW; Peterson BR; Steenbergen JL; Jobe PC; Eells JB; Browning RA; Mishra PK
    Epilepsy Res; 1998 Jan; 29(2):135-46. PubMed ID: 9477146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions.
    Reigel CE; Jobe PC; Dailey JW; Stewart JJ
    Life Sci; 1988; 42(18):1743-9. PubMed ID: 3362037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats.
    Statnick MA; Maring-Smith ML; Clough RW; Wang C; Dailey JW; Jobe PC; Browning RA
    Life Sci; 1996; 59(21):1763-71. PubMed ID: 8937503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Jobe PC
    Epilepsia; 1986; 27(6):665-70. PubMed ID: 2877867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
    Yan QS; Dailey JW; Steenbergen JL; Jobe PC
    Brain Res; 1998 Jan; 780(2):199-209. PubMed ID: 9507130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying modifications in the severity of audiogenic convulsions.
    Lehmann A
    Life Sci; 1977 Jun; 20(12):2047-59. PubMed ID: 587242
    [No Abstract]   [Full Text] [Related]  

  • 20. Noradrenergic abnormalities in the genetically epilepsy-prone rat.
    Jobe PC; Mishra PK; Browning RA; Wang C; Adams-Curtis LE; Ko KH; Dailey JW
    Brain Res Bull; 1994; 35(5-6):493-504. PubMed ID: 7859107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.